{"schema_version":"secwatch.filing_event.v1","accession":"0000064803-23-000036","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2023-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.411419+00:00","generated_at":"2026-06-10T21:55:23.043211+00:00","sec_items":["7.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"CVS Health reaffirms FY2023 GAAP EPS $6.53-$6.75, Adjusted EPS $8.50-$8.70, CFO $12.5B-$13.5B","bullets":["Reaffirms FY2023 GAAP diluted EPS range $6.53–$6.75, unchanged from prior guidance.","Reaffirms FY2023 Adjusted EPS range $8.50–$8.70, unchanged.","Reaffirms FY2023 cash flow from operations guidance $12.5B–$13.5B.","Management to present at investor meeting on September 12, 2023; webcast available."],"urls":{"canonical":"https://secwatch.observer/filing/0000064803-23-000036","json":"https://secwatch.observer/filing/0000064803-23-000036.json","markdown":"https://secwatch.observer/filing/0000064803-23-000036.md","text":"https://secwatch.observer/filing/0000064803-23-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000036/0000064803-23-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000036/cvs-20230911.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T21:55:23.043211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}